179 related articles for article (PubMed ID: 22642751)
1. Therapeutic upregulation of Class A scavenger receptor member 5 inhibits tumor growth and metastasis.
Yan N; Zhang S; Yang Y; Cheng L; Li C; Dai L; Dai L; Zhang X; Fan P; Tian H; Wang R; Chen X; Su X; Li Y; Zhang J; Du T; Wei Y; Deng H
Cancer Sci; 2012 Sep; 103(9):1631-9. PubMed ID: 22642751
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.
Huang J; Zheng DL; Qin FS; Cheng N; Chen H; Wan BB; Wang YP; Xiao HS; Han ZG
J Clin Invest; 2010 Jan; 120(1):223-41. PubMed ID: 20038795
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SCARA5 inhibits tumor proliferation and invasion in osteosarcoma via suppression of the FAK signaling pathway.
Wen X; Wang N; Zhang F; Dong C
Mol Med Rep; 2016 Mar; 13(3):2885-91. PubMed ID: 26847210
[TBL] [Abstract][Full Text] [Related]
4. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.
Wang J; Wang S; Chen L; Tan J
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495818
[TBL] [Abstract][Full Text] [Related]
5. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
6. SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways.
You K; Su F; Liu L; Lv X; Zhang J; Zhang Y; Liu B
Mol Cell Biochem; 2017 Nov; 435(1-2):47-58. PubMed ID: 28497372
[TBL] [Abstract][Full Text] [Related]
7. SCARA5 as a downstream factor of PCAT29, inhibits proliferation, migration, and invasion of bladder cancer.
Lu XS; Huang ML; Chen LB; Liu SC; Huang ZX; Liu SM
Genomics; 2023 Sep; 115(5):110667. PubMed ID: 37315873
[TBL] [Abstract][Full Text] [Related]
8. Methylated tumor suppressor gene
Jiang X; Jiang Y; An D; Jiang X; Zhou S; Liu Y; Tian R; Li Z; Zhao X; Xiang T; Ji P; Yang Y
Epigenomics; 2023 Jun; 15(11):635-650. PubMed ID: 37554122
[No Abstract] [Full Text] [Related]
9. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
10. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
[TBL] [Abstract][Full Text] [Related]
11. m
Lu X; Chen L; Liu S; Cao Y; Huang Z
Epigenomics; 2023 Apr; 15(7):401-415. PubMed ID: 37337726
[No Abstract] [Full Text] [Related]
12. Knockdown of SCARA5 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppression of the PDGF signaling pathway.
Zhao J; Jian L; Zhang L; Ding T; Li X; Cheng D; Niu S; Sun L; Li E; Liu S; Jiang Y; Liu L
Mol Med Rep; 2016 May; 13(5):4455-60. PubMed ID: 27035566
[TBL] [Abstract][Full Text] [Related]
13. Identification of
Wang F; Cao X; Yin L; Wang Q; He Z
DNA Cell Biol; 2020 Oct; 39(10):1813-1824. PubMed ID: 32816580
[TBL] [Abstract][Full Text] [Related]
14. Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
Jia WQ; Wang ZT; Zou MM; Lin JH; Li YH; Zhang L; Xu RX
Cell Physiol Biochem; 2018; 47(5):1871-1882. PubMed ID: 29961065
[TBL] [Abstract][Full Text] [Related]
15. SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain.
Liu Y; Xiong R; Xiao T; Xiong L; Wu J; Li J; Feng G; Song G; Liu K
BMC Cancer; 2022 Dec; 22(1):1304. PubMed ID: 36513999
[TBL] [Abstract][Full Text] [Related]
16. Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis.
Liu Y; Tan YR; Sun WW; Ju WT; Fu Y; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
Proteomics Clin Appl; 2018 Sep; 12(5):e1700180. PubMed ID: 29461673
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency.
Kenagy RD; Civelek M; Kikuchi S; Chen L; Grieff A; Sobel M; Lusis AJ; Clowes AW
J Vasc Surg; 2016 Jul; 64(1):202-209.e6. PubMed ID: 25935274
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation.
Ulker D; Ersoy YE; Gucin Z; Muslumanoglu M; Buyru N
Gene; 2018 Oct; 673():102-106. PubMed ID: 29908284
[TBL] [Abstract][Full Text] [Related]
19. Rock2 promotes RCC proliferation by decreasing SCARA5 expression through β-catenin/TCF4 signaling.
Xu Z; Hong Z; Ma M; Liu X; Chen L; Zheng C; Xi X; Shao J
Biochem Biophys Res Commun; 2016 Nov; 480(4):586-593. PubMed ID: 27793664
[TBL] [Abstract][Full Text] [Related]
20. SCARA5 in bone marrow stromal cell-derived exosomes inhibits colorectal cancer progression by inactivating the PI3K/Akt pathway.
Fang Y; Wu F; Shang G; Yin C
Genomics; 2023 Jul; 115(4):110636. PubMed ID: 37150230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
